Notice Pursuant to the National Cooperative Research and Production Act of 1993-Biopharmaceutical Manufacturing Preparedness Consortium, 82628-82629 [2024-23597]

Download as PDF 82628 Federal Register / Vol. 89, No. 198 / Friday, October 11, 2024 / Notices Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Alabama Institute for Deaf and Blind, East Talladega, AL; Education Assessment System, Arlington, VA; University of Georgia, Athens, GA; School Harbor, Phoenix, AZ; Ivy Tech Community College, Indianapolis, IN; MyEducator LLC, Orem, UT; Mountain Brook Schools, Mountain Brook, AL; Uinta County School District #1, Evanston, WY; St. Charles CUSD 303, St. Charles, IL; Swedish National Agency for Education (Statens skolverk), Stockholm, SWEDEN; Massachusetts Institute of Technology, Cambridge, MA; and Vestavia Hills City Schools, Vestavia Hills, AL, have been added as parties to this venture. Also, Washington State Community and Technical Colleges System, Olympia, WA; Pearl, Richmond, VA; New Hanover County Schools, Wilmington, NC; and Edge Factor Inc., Ontario, CANADA, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and 1EdTech Consortium intends to file additional written notifications disclosing all changes in membership. On April 7, 2000, 1EdTech Consortium filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on September 13, 2000 (65 FR 55283). The last notification was filed with the Department on April 29, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on June 21, 2024 (89 FR 52089). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–23594 Filed 10–10–24; 8:45 am] BILLING CODE P ddrumheller on DSK120RN23PROD with NOTICES1 DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Z-Wave Alliance Notice is hereby given that, on July 15, 2024, pursuant to section 6(a) of the National Cooperative Research and VerDate Sep<11>2014 17:15 Oct 10, 2024 Jkt 265001 Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Z-Wave Alliance, Inc. (the ‘‘Joint Venture’’) filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, EcoDim, Doetinchem, Gelderland, NETHERLANDS; Hank Smart Tech Co. Ltd., Shenzhen, PEOPLE’S REPUBLIC OF CHINA; Leak Intelligence LLC, Franklin, TN; M2M Services, Hoofddorp, NETHERLANDS; Keaton Chia (University of California, San Diego (Kleissl Lab)), La Jolla, CA; BSmartfoils, Rauenberg, GERMANY; HAB Home Intelligence, Arlington, TX; Shenzhen Neo Electronics Co., Ltd., Shenzhen, PEOPLE’S REPUBLIC OF CHINA; Shenzhen Sunricher Technology Limited, Shenzhen, PEOPLE’S REPUBLIC OF CHINA; and Springs Window Fashions, LLC, Middleton, WI, have been added as parties to the venture. Also, Atsumi Electric, Shizuoka, JAPAN; B-Smart Integration, Rauenberg, GERMANY; GOAP Racunalniski inzeniring in avtomatizacija procesov d.o.o. Nova Gorica, Solkan, SLOVENIA; Shenzhen Shyugj Technology Co., Ltd., Guangdon, PEOPLE’S REPUBLIC OF CHINA; ZoneSystems.est, Khobar City, SAUDI ARABIA; and Ochsner Clinic Foundation, New Orleans, LA, have withdrawn as parties to the venture. No other changes have been made in either the membership or the planned activity of the venture. Membership in this venture remains open, and the Joint Venture intends to file additional written notifications disclosing all changes in membership. On November 19, 2020, the Joint Venture filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on December 1, 2020 (85 FR 77241). The last notification was filed with the Department on June 14, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on July 29, 2024 (89 FR 60918). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–23595 Filed 10–10–24; 8:45 am] BILLING CODE P PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cable Television Laboratories, Inc. Notice is hereby given that, on August 19, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Cable Television Laboratories, Inc. (‘‘CableLabs’’) filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Shenzen Topway Video Communication Co., Ltd., Shenzen, Guangdong, PEOPLE’S REPUBLIC OF CHINA; and Henan Cable TV Network Group Co., Ltd., Zhengzhou, PEOPLE’S REPUBLIC OF CHINA, have been terminated as parties to this venture. No other changes have been made in either the membership or planned activity of the venture. Membership in this venture remains open, and CableLabs intends to file additional written notifications disclosing all changes in membership. On August 8, 1988, CableLabs filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on September 7, 1988 (53 FR 34593). The last notification was filed with the Department on May 17, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on June 21, 2024 (89 FR 52096). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–23619 Filed 10–10–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Biopharmaceutical Manufacturing Preparedness Consortium Notice is hereby given that, on July 11, 2024, pursuant to section 6(a) of the National Cooperative Research and E:\FR\FM\11OCN1.SGM 11OCN1 ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 89, No. 198 / Friday, October 11, 2024 / Notices Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Biopharmaceutical Manufacturing Preparedness Consortium (‘‘BioMaP-Consortium’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Arena BioPharma Consulting LLC, Athens, GA; ReechPharma LLC, Newark, CA; Repligen Corp., Waltham, WA; RexSter Technologies, Inc., Acton, MA; VJ Technologies, Inc., Bohemia, NY; Altor Safety LLC, Valley Cottage, NY; Anverra Pharma LLC, Mt. Pleasant, SC; Arranat Bio MA LLC, Watertown, MA; BioTechnique LLC, York, PA; Celltheon, Union City, CA; CHO Plus, Inc., South San Francisco, CA; Cocoon Bioscience S.L., Derio, SPAIN; CONTINUUS Pharmaceuticals, Inc., Woburn, MA; Convergence, Oklahoma City, OK; DNA Script, Daly City, CA; Evonik Corp., Piscataway, NJ; Gerresheimer Glass, Inc., Vineland, NJ; Innoviva Specialty Therapeutics, Waltham, MA; KBI Biopharma, Durham, NC; Orexo AB, Morristown, NJ; Persist AI Formulations Corp., West Sacramento, CA; Phenom Pharmaceuticals LLC, Miami Beach, FL; Shionogi, Inc., Florham Park, NJ; Solaris Vaccines, Inc., Fort Collins, CO; Spring Discovery, Inc., San Carlos, CA; Sublime LLC, Ann Arbor, MI, Watson-Marlow, Inc., Wilmington, MA; Apotex Corp., Weston, FL; Avid Bioservices, Inc., Tustin, CA; Burrell International Group LLC, Washington, DC; Dark Wolf Solutions LLC, Herdon, VA; GENEVATIONUS LLC, Sacramento, CA; Gusmer Enterprises, Inc., Mountainside, NJ; Integrated Pharma Services, Rockville, MD; Replicate Bioscience, San Diego, CA; Seqirus, Inc., Holly Springs, NC; Signet Healthcare Management LLC, New York, NY; Sterigenics Radiation Technologies LLC, Oak Brook, IL; The Albert B. Sabin Vaccine Institute, Inc., Washington, DC; Virica Biotech, Ottawa, CANADA; Agile GxP Technologies, Providence, RI; Allied Technologies and Consulting LLC, Frederick, MD; Global Key Solutions Corp., Dalton, PA; Industrial Info Resources, Inc., Sugar Land, TX; Prince Sterilization Services LLC, Pine Brook, NJ; Curia Global, Inc., Albany, NY; Donaldson Company, Inc., Bloomington, MN; GCM Pharma, St. Louis, MO; Photosynthetic B.V., Amsterdam, NETHERLANDS; Revagenix, Inc., San Francisco, CA; VerDate Sep<11>2014 17:15 Oct 10, 2024 Jkt 265001 Agno Pharmaceuticals LLC, Bethlehem, PA; BioAnalysis LLC, Philadelphia, PA; Cornerstone Government Affairs, Inc., Washington, DC; Cytophage Technologies, Inc., Winnipeg, CANADA; Humanetics Corp., Edina, MN; NorthX Biologics AB, Matfors, SWEDEN; Novavax, Inc., Gaithersburg, MD; Quantiscope PBC, Salt Lake City, UT; Stoic Bio, Inc., San Diego, CA; and Sunflower Therapeutics PBC, Hingham, MA, have been added as parties to this venture. Also, Quantum Four Labs LLC, Arcadia, CA, has withdrawn as party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and the BioMaPConsortium intends to file additional written notifications disclosing all changes in membership. On January 5, 2024, the BioMaPConsortium filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on April 16, 2024 (89 FR 26923). The last notification was filed with the Department on April 12, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on June 21, 2024 (89 FR 52097). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–23597 Filed 10–10–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—PXI Systems Alliance, Inc. Notice is hereby given that, on August 2, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), PXI Systems Alliance, Inc. (‘‘PXI Systems’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Wuhan Pusaisi Electronics Co., Ltd (Pultiwave), Wuhan City, PEOPLE’S PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 82629 REPUBLIC OF CHINA, has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PXI Systems intends to file additional written notifications disclosing all changes in membership. On November 22, 2000, PXI Systems filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on March 8, 2001 (66 FR 13971). The last notification was filed with the Department on May 23, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on June 24, 2024 (89 FR 52508). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–23615 Filed 10–10–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Consortium for Rare Earth Technologies Notice is hereby given that, on July 18, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Consortium for Rare Earth Technologies (‘‘CREaTe’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Watts & Fisher Pty Ltd, Mandurah, WA; Alkemio, San Francisco, CA; Fluid Photonics Corporation, Lindenhurst, NY; MTL Corp., Bloomington, MN; and Precision Combustion, Inc., North Haven, CT, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and CREaTe intends to file additional written notifications disclosing all changes in membership. E:\FR\FM\11OCN1.SGM 11OCN1

Agencies

[Federal Register Volume 89, Number 198 (Friday, October 11, 2024)]
[Notices]
[Pages 82628-82629]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23597]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Biopharmaceutical Manufacturing Preparedness 
Consortium

    Notice is hereby given that, on July 11, 2024, pursuant to section 
6(a) of the National Cooperative Research and

[[Page 82629]]

Production Act of 1993, 15 U.S.C. 4301 et seq. (``the Act''), 
Biopharmaceutical Manufacturing Preparedness Consortium (``BioMaP-
Consortium'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances.
    Specifically, Arena BioPharma Consulting LLC, Athens, GA; 
ReechPharma LLC, Newark, CA; Repligen Corp., Waltham, WA; RexSter 
Technologies, Inc., Acton, MA; VJ Technologies, Inc., Bohemia, NY; 
Altor Safety LLC, Valley Cottage, NY; Anverra Pharma LLC, Mt. Pleasant, 
SC; Arranat Bio MA LLC, Watertown, MA; BioTechnique LLC, York, PA; 
Celltheon, Union City, CA; CHO Plus, Inc., South San Francisco, CA; 
Cocoon Bioscience S.L., Derio, SPAIN; CONTINUUS Pharmaceuticals, Inc., 
Woburn, MA; Convergence, Oklahoma City, OK; DNA Script, Daly City, CA; 
Evonik Corp., Piscataway, NJ; Gerresheimer Glass, Inc., Vineland, NJ; 
Innoviva Specialty Therapeutics, Waltham, MA; KBI Biopharma, Durham, 
NC; Orexo AB, Morristown, NJ; Persist AI Formulations Corp., West 
Sacramento, CA; Phenom Pharmaceuticals LLC, Miami Beach, FL; Shionogi, 
Inc., Florham Park, NJ; Solaris Vaccines, Inc., Fort Collins, CO; 
Spring Discovery, Inc., San Carlos, CA; Sublime LLC, Ann Arbor, MI, 
Watson-Marlow, Inc., Wilmington, MA; Apotex Corp., Weston, FL; Avid 
Bioservices, Inc., Tustin, CA; Burrell International Group LLC, 
Washington, DC; Dark Wolf Solutions LLC, Herdon, VA; GENEVATIONUS LLC, 
Sacramento, CA; Gusmer Enterprises, Inc., Mountainside, NJ; Integrated 
Pharma Services, Rockville, MD; Replicate Bioscience, San Diego, CA; 
Seqirus, Inc., Holly Springs, NC; Signet Healthcare Management LLC, New 
York, NY; Sterigenics Radiation Technologies LLC, Oak Brook, IL; The 
Albert B. Sabin Vaccine Institute, Inc., Washington, DC; Virica 
Biotech, Ottawa, CANADA; Agile GxP Technologies, Providence, RI; Allied 
Technologies and Consulting LLC, Frederick, MD; Global Key Solutions 
Corp., Dalton, PA; Industrial Info Resources, Inc., Sugar Land, TX; 
Prince Sterilization Services LLC, Pine Brook, NJ; Curia Global, Inc., 
Albany, NY; Donaldson Company, Inc., Bloomington, MN; GCM Pharma, St. 
Louis, MO; Photosynthetic B.V., Amsterdam, NETHERLANDS; Revagenix, 
Inc., San Francisco, CA; Agno Pharmaceuticals LLC, Bethlehem, PA; 
BioAnalysis LLC, Philadelphia, PA; Cornerstone Government Affairs, 
Inc., Washington, DC; Cytophage Technologies, Inc., Winnipeg, CANADA; 
Humanetics Corp., Edina, MN; NorthX Biologics AB, Matfors, SWEDEN; 
Novavax, Inc., Gaithersburg, MD; Quantiscope PBC, Salt Lake City, UT; 
Stoic Bio, Inc., San Diego, CA; and Sunflower Therapeutics PBC, 
Hingham, MA, have been added as parties to this venture.
    Also, Quantum Four Labs LLC, Arcadia, CA, has withdrawn as party to 
this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and the BioMaP-Consortium intends to 
file additional written notifications disclosing all changes in 
membership.
    On January 5, 2024, the BioMaP- Consortium filed its original 
notification pursuant to section 6(a) of the Act. The Department of 
Justice published a notice in the Federal Register pursuant to section 
6(b) of the Act on April 16, 2024 (89 FR 26923).
    The last notification was filed with the Department on April 12, 
2024. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on June 21, 2024 (89 FR 52097).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-23597 Filed 10-10-24; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.